Abbott faces antitrust suit
- Share via
From Times Wire Services
Eighteen states have filed suit in federal court against Abbott Laboratories, saying the drug maker blocked generic competition for a popular cholesterol medication.
The antitrust lawsuit charges that Abbott Park, Ill.-based Abbott and a French drug company tried to block competition for a cheaper, generic version of the prescription drug TriCor. The states allege that the firms continuously made minor changes in the formulations of TriCor to prevent generic versions from entering the market.
More to Read
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
